Cite
Fragment-Based Drug Design Facilitated by Protein-Templated Click Chemistry: Fragment Linking and Optimization of Inhibitors of the Aspartic Protease Endothiapepsin.
MLA
Mondal, Milon, et al. “Fragment-Based Drug Design Facilitated by Protein-Templated Click Chemistry: Fragment Linking and Optimization of Inhibitors of the Aspartic Protease Endothiapepsin.” Chemistry (Weinheim an Der Bergstrasse, Germany), vol. 22, no. 42, Oct. 2016, pp. 14826–30. EBSCOhost, https://doi.org/10.1002/chem.201603001.
APA
Mondal, M., Unver, M. Y., Pal, A., Bakker, M., Berrier, S. P., & Hirsch, A. K. H. (2016). Fragment-Based Drug Design Facilitated by Protein-Templated Click Chemistry: Fragment Linking and Optimization of Inhibitors of the Aspartic Protease Endothiapepsin. Chemistry (Weinheim an Der Bergstrasse, Germany), 22(42), 14826–14830. https://doi.org/10.1002/chem.201603001
Chicago
Mondal, Milon, M Yagiz Unver, Asish Pal, Matthijs Bakker, Stephan P Berrier, and Anna K H Hirsch. 2016. “Fragment-Based Drug Design Facilitated by Protein-Templated Click Chemistry: Fragment Linking and Optimization of Inhibitors of the Aspartic Protease Endothiapepsin.” Chemistry (Weinheim an Der Bergstrasse, Germany) 22 (42): 14826–30. doi:10.1002/chem.201603001.